| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |